Advertisement
For older adults

Brain Changes May Mark Risk of Financial Exploitation in Seniors

0
Differences in brain regions associated with social, emotional function seen in financially exploited seniors
Nine out of 10 American doctors are happy with their choice of profession

90 Percent of U.S. Physicians Satisfied With Career Choice

0
AMA survey of physicians, residents, and medical students finds most are satisfied despite challenges
For patients with dementia

Proton Pump Inhibitor Use Ups Pneumonia Risk in Dementia

0
Independent risk factors for pneumonia include age, male gender, underlying cerebrovascular disease
Patients with chronic tension-type headache have impairments in cognitive ability and dysfunction in the neuroendocrine state

Chronic Tension-Type Headache Tied to Cognitive Impairment

0
Impairment may result from neuroendocrine dysfunction
There seems to be a positive association for extremely low-frequency magnetic fields exposure with amyotrophic lateral sclerosis mortality in men

Extremely Low-Frequency Magnetic Fields Tied to ALS Death

0
Possible association for ALS mortality with occupational exposure to ELF-MFs in men
For patients with high-cervical spinal cord injury

Arm, Hand Function Restored in Tetraplegic Patient

0
Researchers utilized functional electric stimulation + intracortical brain-computer interface system
Individuals with hepatitis B and hepatitis C have increased rates of subsequent Parkinson's disease

Hepatitis B, C Linked to Higher Subsequent Rates of Parkinson’s

0
Increased rates of subsequent Parkinson's for those with hepatitis B, C, but not autoimmune hepatitis
The causal links between Zika virus infection

Study Explores Links Between Zika, GBS, Microcephaly in Brazil

0
Apparent resurgence of Zika virus and GBS early in 2016, but no subsequent increase in microcephaly
The intravenous drug Ocrevus (ocrelizumab) has been approved by the U.S. Food and Drug Administration to treat adults with primary progressive multiple sclerosis and relapsing forms of the disease

FDA Approves Ocrevus to Treat Severe Form of Multiple Sclerosis

0
First drug sanctioned in United States for primary progressive multiple sclerosis
In a position paper published online March 28 in the Annals of Internal Medicine

ACP Issues Challenge to Cut Task Burden and Put Patients First

0
American College of Physicians details policy recommendations to reduce administrative burden